These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 21930973)

  • 1. Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells.
    Joshi NS; Cui W; Dominguez CX; Chen JH; Hand TW; Kaech SM
    J Immunol; 2011 Oct; 187(8):4068-76. PubMed ID: 21930973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.
    Intlekofer AM; Takemoto N; Kao C; Banerjee A; Schambach F; Northrop JK; Shen H; Wherry EJ; Reiner SL
    J Exp Med; 2007 Sep; 204(9):2015-21. PubMed ID: 17698591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.
    Rao RR; Li Q; Odunsi K; Shrikant PA
    Immunity; 2010 Jan; 32(1):67-78. PubMed ID: 20060330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infection.
    Omilusik KD; Best JA; Yu B; Goossens S; Weidemann A; Nguyen JV; Seuntjens E; Stryjewska A; Zweier C; Roychoudhuri R; Gattinoni L; Bird LM; Higashi Y; Kondoh H; Huylebroeck D; Haigh J; Goldrath AW
    J Exp Med; 2015 Nov; 212(12):2027-39. PubMed ID: 26503445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.
    Banerjee A; Gordon SM; Intlekofer AM; Paley MA; Mooney EC; Lindsten T; Wherry EJ; Reiner SL
    J Immunol; 2010 Nov; 185(9):4988-92. PubMed ID: 20935204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Context-Dependent Role for IL-21 in Modulating the Differentiation, Distribution, and Abundance of Effector and Memory CD8 T Cell Subsets.
    Tian Y; Cox MA; Kahan SM; Ingram JT; Bakshi RK; Zajac AJ
    J Immunol; 2016 Mar; 196(5):2153-66. PubMed ID: 26826252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells.
    Li G; Yang Q; Zhu Y; Wang HR; Chen X; Zhang X; Lu B
    PLoS One; 2013; 8(6):e67401. PubMed ID: 23826287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrogenic ICOS Expression Increases Differentiation of KLRG-1hiCD127loCD8+ T Cells during Listeria Infection and Diminishes Recall Responses.
    Liu D; Burd EM; Coopersmith CM; Ford ML
    J Immunol; 2016 Feb; 196(3):1000-12. PubMed ID: 26729800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preexisting high frequencies of memory CD8+ T cells favor rapid memory differentiation and preservation of proliferative potential upon boosting.
    Fraser KA; Schenkel JM; Jameson SC; Vezys V; Masopust D
    Immunity; 2013 Jul; 39(1):171-83. PubMed ID: 23890070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation.
    Rao RR; Li Q; Gubbels Bupp MR; Shrikant PA
    Immunity; 2012 Mar; 36(3):374-87. PubMed ID: 22425248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells.
    Mitchell DM; Ravkov EV; Williams MA
    J Immunol; 2010 Jun; 184(12):6719-30. PubMed ID: 20483725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.
    Takemoto N; Intlekofer AM; Northrup JT; Wherry EJ; Reiner SL
    J Immunol; 2006 Dec; 177(11):7515-9. PubMed ID: 17114419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eomesodermin driven IL-10 production in effector CD8
    Reiser J; Sadashivaiah K; Furusawa A; Banerjee A; Singh N
    Cell Immunol; 2019 Jan; 335():93-102. PubMed ID: 30528350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection.
    Jung YW; Rutishauser RL; Joshi NS; Haberman AM; Kaech SM
    J Immunol; 2010 Nov; 185(9):5315-25. PubMed ID: 20921525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.
    Pipkin ME; Sacks JA; Cruz-Guilloty F; Lichtenheld MG; Bevan MJ; Rao A
    Immunity; 2010 Jan; 32(1):79-90. PubMed ID: 20096607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.
    Kalia V; Sarkar S; Subramaniam S; Haining WN; Smith KA; Ahmed R
    Immunity; 2010 Jan; 32(1):91-103. PubMed ID: 20096608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection.
    Dominguez CX; Amezquita RA; Guan T; Marshall HD; Joshi NS; Kleinstein SH; Kaech SM
    J Exp Med; 2015 Nov; 212(12):2041-56. PubMed ID: 26503446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation.
    Iborra S; Ramos M; Arana DM; Lázaro S; Aguilar F; Santos E; López D; Fernández-Malavé E; Del Val M
    J Exp Med; 2013 Jul; 210(7):1463-79. PubMed ID: 23776078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
    Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
    Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.